Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INFLAMA Trial: Ibuprofen vs Conventional Treatment in Acute Myocarditis
NCT06686862Phase 3Recruiting
- Sponsor
- Centro Nacional de Investigaciones Cardiovasculares
- Start
- Apr 2025
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ibuprofen in acute myocarditis (2 arms), sponsored by Centro Nacional de Investigaciones Cardiovasculares. Primary endpoint: Change in late gadolinium enhancement at 6 months. Started Apr 2025; status: recruiting.
02
Drugs
ibuprofen
03
Conditions
acute myocarditis
Beyond the preview
Go deeper on NCT06686862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06686862.